How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

ACS Interactions brings programs and sessions on innovation, skill development, and scientific discussions. This diverse program features curated scientific discussions, thought-provoking leadership ...

Find the course descriptions you're looking for, all in one place. You have decisions to make. Important ones. So take your time. Browse through the catalogs below that describe our undergraduate ...

In her 2024 Reith Lectures, Dr Gwen Adshead addresses the most pertinent questions that she has faced in her work as a forensic psychiatrist in secure psychiatric units and prisons Forensic ...

Mark Carney, former Governor of the Bank of England, argues that changing attitudes to value and the marketplace have contributed to a trio of crises: credit, Covid and climate. Why have financial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.